Decolonization to Reduce After-Surgery Events of Surgical Site Infection
Start Date
1/17/2023
Completion Date
12/1/2027
Summary
The DECREASE SSI Trial (Decolonization to Reduce After-Surgery Events of Surgical Site Infection) is a two-arm multi-center individual placebo-controlled randomized (2,700 participants randomized 1:1) clinical trial to reduce post-discharge surgical site infection following open colon or small bowel surgery by comparing chlorhexidine bathing plus nasal mupirocin in the 30 days following discharge to soap without antiseptic properties (placebo) and placebo nasal ointment. This trial seeks to enhance the care of the 675,000 patients annually who undergo colon and small bowel surgery by finding simple and efficacious interventions to reduce SSI.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
4% Chlorhexidine Gluconate
2% Mupirocin
Soap Without Antiseptic Properties (Placebo)
Placebo Nasal Ointment
Conditions
Locations
Hoag Memorial Hospital Presbyterian
Newport Beach, California 92663
United States
University of California, Irvine Medical Center
Orange, California 92868
United States
University of California, Davis Medical Center
Sacramento, California 95817
United States
University of California, San Francisco Medical Center
San Francisco, California 94143
United States